Literature DB >> 3263447

Production of tumor necrosis factor by human monocytes in response to toxic-shock-syndrome toxin-1.

J Parsonnet1, Z A Gillis.   

Abstract

We studied the effect of toxic-shock-syndrome toxin-1 (TSST-1) on production of tumor necrosis factor (TNF) by human monocytes. Adherent mononuclear cells were stimulated with TSST-1 and their supernatants assayed for TNF by using L929 cells in a cytotoxicity assay. TSST-1 stimulated production of TNF over a wide range of concentrations. The cytotoxicity of monocyte supernatants was neutralized by antibody to TNF but not by antibody to interleukin-1 or by normal rabbit serum. TSST-1 and lipopolysaccharide (LPS) had a synergistic effect on monokine production. Monocytes "primed" with TSST-1 produced more interleukin-1 and TNF in response to LPS than did unprimed cells. Treating monocytes with LPS before TSST-1 and co-incubating the two agents with cells for 24 h also enhanced monokine production under some circumstances. These studies suggest a role for TNF in the pathogenesis of toxic shock syndrome, as a consequence of induction by TSST-1 alone or the synergistic effects of several bacterial products.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3263447     DOI: 10.1093/infdis/158.5.1026

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  41 in total

1.  Enterotoxin and toxic shock syndrome toxin-1 production of methicillin resistant and methicillin sensitive Staphylococcus aureus strains.

Authors:  F J Schmitz; C R MacKenzie; R Geisel; S Wagner; H Idel; J Verhoef; U Hadding; H P Heinz
Journal:  Eur J Epidemiol       Date:  1997-09       Impact factor: 8.082

2.  B-cell maturation in chronic lymphocytic leukaemia. IV. T-cell-dependent activation of leukaemic B cells by staphylococcal enterotoxin 'superantigens'.

Authors:  X Duan; C Nerl; O Janssen; D Kabelitz
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

3.  Postoperative enteritis caused by methicillin-resistant Staphylococcus aureus.

Authors:  T Kodama; T Santo; T Yokoyama; Y Takesue; E Hiyama; Y Imamura; Y Murakami; H Tsumura; K Shinbara; N Tatsumoto; Y Matsuura
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

4.  Supernatants from Staphylococcus epidermidis grown in the presence of different antibiotics induce differential release of tumor necrosis factor alpha from human monocytes.

Authors:  E Mattsson; H Van Dijk; J Verhoef; R Norrby; J Rollof
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

5.  Pentoxifylline inhibits superantigen-induced toxic shock and cytokine release.

Authors:  T Krakauer; B G Stiles
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

6.  Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: implications for chronic inflammatory acne.

Authors:  B R Vowels; S Yang; J J Leyden
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

7.  Induction of release of tumor necrosis factor from human monocytes by staphylococci and staphylococcal peptidoglycans.

Authors:  C P Timmerman; E Mattsson; L Martinez-Martinez; L De Graaf; J A Van Strijp; H A Verbrugh; J Verhoef; A Fleer
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

8.  Staphylococcal exotoxins deliver activation signals to human T-cell clones via major histocompatibility complex class II molecules.

Authors:  F Spertini; H Spits; R S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

9.  Biological activity of toxic shock syndrome toxin 1 and a site-directed mutant, H135A, in a lipopolysaccharide-potentiated mouse lethality model.

Authors:  B G Stiles; T Krakauer; P F Bonventre
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

10.  Capsular polysaccharide types 5 and 8 of Staphylococcus aureus bind specifically to human epithelial (KB) cells, endothelial cells, and monocytes and induce release of cytokines.

Authors:  M Soell; M Diab; G Haan-Archipoff; A Beretz; C Herbelin; B Poutrel; J P Klein
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.